Contraceptives Market Size By Product [Drugs {Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives}, Devices {Condoms (Male, Female), Diaphragms, Contraceptive Sponges, Vaginal Rings, Subdermal Implants, Intra-uterine Devices (Copper, Hormonal)}], By Age (15-19, 20-29, 30-39, 40-49), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Japan, China, India, South Korea, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Feb 2019 |    |  Report ID: GMI430  |  Authors: Sumant Ugalmugale, Rupali Swain

Report Format: PDF   |   Pages: 185   |   Base Year: 2018

Summary Table of Contents Industry Coverage Methodology

Industry Trends

Contraceptives Market size was valued over USD 24,118.1 million in 2018 and is expected to witness 6.9% CAGR from 2019 to 2025.   

U.S. contraceptives market, by product, 2018 & 2025 (USD Million)
U.S. contraceptives market, by product, 2018 & 2025 (USD Million)

Get more details on this report - Request Free Sample PDF

Rising government initiatives to promote awareness regarding unintended pregnancies and increasing population will create huge demand for contraceptives during the forecast period. Various programs aiming to meet the need for modern contraception and provide reproductive and sexual health services should involve a good participation of women, adolescents, and young people, at all stages of planning, implementation, and evaluation.

An increasing number of women are postponing motherhood as they prioritize their careers. Moreover, balancing concerns of the cost for raising a child, ambiguity over job safety and unstable relationships are increasingly causing women to postpone pregnancy.

In 2015, globally 64% of in-union or married women of fertile age were using some mode of contraception. Nevertheless, contraceptive use was much lesser in the under developed countries and was particularly low in Africa where only 33% of women are projected to use the products so far. High unmet needs in developing nation will fuel the market size. Demand for contraceptives would rise owing to rising numbers of new HIV infections in many countries over the coming years.

Growing geriatric population across European nations coupled with rising incidence of lifestyle disorders will induce infertility eventually reducing the demand for contraception products. Moreover, concerns regarding the side effects of products can negatively impact the product demand in future.

Contraceptives Market Report Coverage
Report Coverage Details
Base Year: 2018
Historical Data for: 2014 to 2018 Forecast Period: 2019 to 2025
Pages: 185 Tables, Charts & Figures: 363
Geographies covered (19): U.S., Canada, Germany, UK, France, Spain, Italy, Russia, Japan, China, India, South Korea, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE
Segments covered: Product and Region
Companies covered (10): Allergan Plc, Bayer Corporation, Cooper Surgical, Inc., Church & Dwight Co., Inc., Mayer Laboratories, Inc., Merck & Co. Inc., Pfizer, Reckitt Benckiser Group Plc, Teva Pharmaceuticals Industries Ltd., The Female Health Company/Veru Inc.

Request 15% Free Customization on this Report

Contraceptives Market, By Product

Germany contraceptives market share, by product, 2018
Germany contraceptives market share, by product, 2018

Get more details on this report - Request Free Sample PDF

Contraceptive devices hold major market share and valued around USD 16,659.0 million in the year 2018. The growth is attributed to more effectiveness and long-term effect. The segment is rapidly adopted worldwide and will continue to grow during the forecast period. Some of the commonly used devices are condoms, diaphragms, sponges, rings, sub-dermal implants and intrauterine devices (IUD). Condoms are most popular choice worldwide and hold largest market share. Copper IUD is mainly preferred by the women who do not wish to use hormonal form to avoid possible side effects.


Contraceptive drugs will witness robust growth at 4.8% over the projection period. The major reasons for the growth of the market will be rising prevalence of STDs and lack of family planning. Favourable regulatory scenario and awareness programs will strengthen segment growth. Various forms of drugs include hormonal oral pills, topical and injectable contraceptives. Oral pills market held major revenue share due to high consumption rate. Daily consumption of these pills facilitates acne reduction, reduces cramping during periods, and minimizes the risk of developing cervical & endometrial cancers powering the overall market growth. However, irregular bleeding, increased risk of developing sexually transmitted infections (STIs), nausea, and migraine are some of the disadvantages related with oral pills eventually hampering segment growth.

Contraceptives Market, By Age

The use of contraceptives in age group 20-29 will be high and valued around USD 8,505.6 million in the year 2018. As per the recent article, almost 50% of the pregnancies in the U.S. are unplanned and unwanted, and out of those around 42% end up in abortion. Hence, increase in number of teenage or early pregnancy will result in augmenting the demand and adoption rate of contraceptives, fueling the business growth in the forthcoming years.

The use of contraceptives in age group 30-39 is estimated to witness significant growth at 7.2% over the forecast period. Increase in trend of delayed pregnancy among the women in the developing and developed economies will result in rise in use of contraceptives, enhancing the industry growth.

Contraceptives Market, By Region

Europe contraceptives market, by country, 2025 (USD Million)
Europe contraceptives market, by country, 2025 (USD Million)

Get more details on this report - Request Free Sample PDF

U.S. dominated the North America contraceptives market and held major revenue share amounting around USD 6,116.5 million in the year 2018. The growth in contraceptives market was attributed to presence of sophisticated healthcare facilities, growing demand for contraceptives for preventing unwanted pregnancies, and favourable regulatory scenario.

Germany contraceptives market is noticeably high compared to the other countries in Europe. Pills are the most popular choice as women are increasingly preferring user dependent forms over the long acting reversible contraceptives. Moreover, availability of sexual health services and a greater number of individuals availing these services to obtain contraceptives and related information will drive the regional revenue share.

India contraceptives market will grow at 9.8% over the projection period owing to rising prevalence of STDs, increasing awareness campaigns to raise awareness about contraceptives and several government initiatives. Favourable family planning policy along with other reimbursement policies such as the AIDS care policy will positively impact business revenue. 

Competitive Market Share

Some of the major players in market are Pfizer, Teva Pharmaceutical Industries, Merck & Co., and Mayer Laboratories. Increased R&D expenditure will offer innovative and efficient products. Other market players Reckitt Benckiser, Cooper Surgical, Church & Dwight Co., and Actavis continuously strive to fortify their market position through investments in R&D for developing new products, agreements, expansion of manufacturing facilities and business collaborations.

Contraceptives Industry Background

Contraceptives Market Segmentation
Get more details on this report - Request Free Sample PDF

Increasing availability of improved drug prescription for individuals, offering safety towards infection and pregnancy, associated factors of pill like decreased risk for cancer will boost the product demand. Technologically advanced product like topical contraceptive, a patch applied to clean, dry skin that releases hormones through the skin will propel the business growth. Contraceptive implants like Implanon is effective for three years and record no pregnancies among the first 70,000 cycles of Implanon users. Other devices like long-acting reversible contraceptives (LARC), intrauterine devices (IUDs) and hormonal implants offer lower infection and unintended pregnancy rate is anticipated to significantly improve control methods.

Buy Now

Single User: $5,150 Access to only 1 person; cannot be shared
Multi User: $7,150 Access for 2 to 5 users only within same department of one company
Enterprise User: $9,150 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Need a Discount? Get in touch with us for special pricing

Inquire Before Buying

Connect with our sales team

Why Global Market Insights, Inc.?

Reliability & accuracy

  • GMI is unparalleled when to comes to the quality of research and information provided to clients. Our unique methodology is designed to ensure a minimum of 90% accuracy to give our clients excellent value on their investment.

Quality & trust

  • BBB Rating - Click to Verify

Customer service

  • Over 200 experts are available across various time-zones, ready to serve clients for their research needs. Our industry experts help clients to design reports customized to their needs.

Security & compliance

Chat With Us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info. I Agree